Your browser doesn't support javascript.
loading
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer.
Reyes, Diane K; Trock, Bruce J; Tran, Phuoc T; Pavlovich, Christian P; Deville, Curtiland; Allaf, Mohamad E; Greco, Stephen C; Song, Daniel Y; Bivalacqua, Trinity J; Han, Misop; Partin, Alan W; Sartor, A Oliver; Rowe, Steven P; Pienta, Kenneth J.
Affiliation
  • Reyes DK; The James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. dreyes@jhmi.edu.
  • Trock BJ; The James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Tran PT; The James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Pavlovich CP; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Deville C; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Allaf ME; The James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Greco SC; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Song DY; The James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Bivalacqua TJ; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Han M; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Partin AW; Department of Surgery, Division of Urology, Pearlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Sartor AO; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Rowe SP; The James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Pienta KJ; Department of Oncology, Tulane Cancer Center, Tulane University, New Orleans, LA, USA.
Med Oncol ; 39(5): 63, 2022 Apr 28.
Article in En | MEDLINE | ID: mdl-35478055
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Type of study: Guideline / Observational_studies Limits: Humans / Male Language: En Journal: Med Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Type of study: Guideline / Observational_studies Limits: Humans / Male Language: En Journal: Med Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Estados Unidos